Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019264

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 019264 describes PENTAM, which is a drug marketed by Fresenius Kabi Usa, Seton Pharms, Baxter Hlthcare, Hospira, and Watson Labs, and is included in six NDAs. It is available from one supplier. Additional details are available on the PENTAM profile page.

The generic ingredient in PENTAM is pentamidine isethionate. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.
Summary for 019264
Applicant:Fresenius Kabi Usa
Ingredient:pentamidine isethionate
Formulation / Manufacturing:see details
Pharmacology for NDA: 019264
Medical Subject Heading (MeSH) Categories for 019264
Suppliers and Packaging for NDA: 019264
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENTAM pentamidine isethionate INJECTABLE;INJECTION 019264 NDA Fresenius Kabi USA, LLC 63323-113 63323-113-10 10 VIAL in 1 TRAY (63323-113-10) > 3 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength300MG/VIAL
Approval Date:Oct 16, 1984TE:APRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.